Compare Medpace Holdings Inc (MEDP) vs Veralto Corp Common Stock (VLTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Veralto Corp Common Stock — how do they compare? Medpace Holdings Inc trades at $616.98 (market cap $17.02B), while Veralto Corp Common Stock trades at $101.5 (market cap $24.13B). The key difference: Veralto Corp Common Stock is the larger of the two by market cap, and Veralto Corp Common Stock pays a 0.53% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Veralto Corp Common Stock for 0 Days on average.
| MEDP | VLTO | |
|---|---|---|
Market Cap | $17.02B | $24.13B |
Volume | 155,250 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $630.19 | $104.87 |
52-Week Low | $393.42 | $82.23 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $16.63B | $25.39B |
Dividend Yield | — | 0.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $609.89, down 1.64% with a bullish technical outlook. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent news highlights CEO stock sales and institutional position adjustments, while Q3 2026 results are expected October 21, 2026.
MEDP offers growth potential with a consensus price target of $620.44 (1.7% upside), supported by projected 2026 revenue growth to $2.8B. Risks include high valuation multiples (P/E 35.82) and insider selling. Analyst sentiment is cautious with 78.95% hold ratings, suggesting limited near-term catalysts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Veralto Corp Common Stock
Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →
